Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.72

-0.58

-0.44

-0.3

Details

Expected EPS

-0.46

Actual EPS

-0.3

Surprise EPS

0.16

Surprise Percent

+34.78%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.3 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.